FPR1 and rheumatoid arthritis: The chemotactic activity of neutrophils obtained from RA patients at baseline was significantly impaired as compared with that in neutrophils from control individuals; the defect was evident both using zymosan-activated serum (P < 0.001; Fig. 1) and FMLP (P < 0.02; Fig. 2) as chemoattractant.